Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01789710 · ClinicalTrials.gov registry record · NA

Contingency Management for Smoking Cessation in Homeless Smokers

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT01789710 is a NA study that has completed, run by Duke University. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01789710, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The purpose of this study is to examine the effectiveness of an internet-based contingency management program for smoking cessation in persons who are homeless. Thirty homeless smokers will be enrolled in the study. Participants will receive payment based on their own low carbon monoxide readings, which indicate being quit from smoking. Participants will be prescribed nicotine replacement (patches and either gum or lozenge)and bupropion. All participants will receive a four sessions of smoking cessation counseling, and will be trained to perform carbon monoxide monitoring with a device provided by the study. They will also be provided with a mobile phone equipped with a video camera, and will use this equipment at home to monitor their carbon monoxide . Participants will record videos of themselves taking a carbon monoxide reading and displaying the results, and will upload the videos to a secured website that is only accessible by the research team members and the participant. Payment will be based on providing carbon monoxide readings that indicate abstinence. The study is designed to address the following aims: Specific Aim 1: To evaluate whether it is feasible to use internet-based contingency management for helping smokers who are homeless stop smoking. Specific Aim 2: To evaluate how effective internet-based contingency managementis on decreasing smoking in smokers who are homeless.

Interventions

  • BEHAVIORAL Contingency Management
  • DRUG Bupropion
  • DRUG Nicotine replacement therapy

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2013-01
Est. Completion 2014-09
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01789710

The ClinicalTrials.gov registry entry for NCT01789710 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Contingency Management is the first listed.

NCT01789710 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01789710 about?

NCT01789710 is a clinical study titled "Contingency Management for Smoking Cessation in Homeless Smokers". The purpose of this study is to examine the effectiveness of an internet-based contingency management program for smoking cessation in persons who are homeless. Thirty homeless smokers will be enrolled in the study. Participants will receive payment based on their own low carbon monoxide readings, w...

What is the current status of trial NCT01789710?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2013-01. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01789710?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Bupropion (DRUG), Nicotine replacement therapy (DRUG).

Who is sponsoring clinical trial NCT01789710?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.